{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:24:42Z","timestamp":1746336282856},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1097\/md.0000000000003534","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T11:25:25Z","timestamp":1463138725000},"page":"e3534","source":"Crossref","is-referenced-by-count":13,"title":["The Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution"],"prefix":"10.1097","volume":"95","author":[{"given":"Seung Tae","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Yun","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeeyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung No","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Kyung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Ah","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Wook","family":"Huh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Beom","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Hyeon","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Cheol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Suk","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-30-20210309","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(63)90951-6","article-title":"The classification of carcinoid tum ours","volume":"1","author":"Williams","year":"1963","journal-title":"Lancet"},{"key":"R2-30-20210309","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.sla.0000129342.67174.67","article-title":"Updated population-based review of carcinoid tumors","volume":"240","author":"Maggard","year":"2004","journal-title":"Ann Surg"},{"key":"R3-30-20210309","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3892\/ijo_00000720","article-title":"Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles","volume":"37","author":"Minoo","year":"2010","journal-title":"Int J Oncol"},{"key":"R4-30-20210309","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"R5-30-20210309","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4143\/crt.2012.44.3.157","article-title":"Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000\u20132009: Multicenter Study","volume":"44","author":"Cho","year":"2012","journal-title":"Cancer Res Treat"},{"key":"R6-30-20210309","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s11605-007-0153-8","article-title":"Viability of endoscopic and excisional treatment of early rectal carcinoids","volume":"11","author":"Merg","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"R7-30-20210309","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.mog.0000239868.27328.1d","article-title":"Rectal carcinoids","volume":"22","author":"Wang","year":"2006","journal-title":"Curr Opin Gastroenterol"},{"key":"R8-30-20210309","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/MPA.0b013e3181ec1261","article-title":"The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum","volume":"39","author":"Anthony","year":"2010","journal-title":"Pancreas"},{"key":"R9-30-20210309","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3393\/jksc.2011.27.1.17","article-title":"Clinical characteristics of colorectal carcinoid tumors.","volume":"27","year":"2011","journal-title":"J Korean Soc Coloproctol"},{"key":"R10-30-20210309","first-page":"S32","article-title":"Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan","volume":"46","author":"Kotake","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"R11-30-20210309","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1743-7563.2011.01423.x","article-title":"Gastroenteropancreatic neuroendocrine tumors: incidence and treatment outcome in a single institution in Korea","volume":"7","author":"Lim","year":"2011","journal-title":"Asia Pac J Clin Oncol"},{"key":"R12-30-20210309","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/COC.0b013e31807a2f49","article-title":"Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital","volume":"31","author":"Rothenstein","year":"2008","journal-title":"Am J Clin Oncol"},{"key":"R13-30-20210309","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1677\/ERC-08-0017","article-title":"Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours","volume":"15","author":"Pape","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"R14-30-20210309","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1677\/erc.1.01017","article-title":"Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization","volume":"12","author":"Panzuto","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"R15-30-20210309","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2005.04.8595","article-title":"Randomized phase III trial comparing irinotecan\/cisplatin with etoposide\/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer","volume":"24","author":"Hanna","year":"2006","journal-title":"J Clin Oncol"},{"key":"R16-30-20210309","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","author":"Rinke","year":"2009","journal-title":"J Clin Oncol"},{"key":"R17-30-20210309","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N Engl J Med"},{"key":"R18-30-20210309","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N Engl J Med"},{"key":"R19-30-20210309","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib malate for the treatment of pancreatic neuroendocrine tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N Engl J Med"},{"key":"R20-30-20210309","first-page":"457","article-title":"The role of chemotherapy and\/or octreotide in patients with metastatic gastroenteropancreatic and hepatobiliary neuroendocrine carcinoma","volume":"5","author":"Lee","year":"2014","journal-title":"J Gastrointest Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003534","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:23:32Z","timestamp":1620959012000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201605100-00030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":20,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003534","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}